5Gabriell GB,et al. Serum laminin and type Ⅲ procollagen in chronic hepatic dignmtic value in the assessment of disease activity and fibrosis[J]. Clin China Acta, 1997,8:265.
5Montgomery BD, Roulot D, George J. Transforming growth factor and the liver. Hepatology ,2001,34 (9) :859-864.
6Shek FW,Benyou RC. How can transforming growth factor beta be targeted ussefully to combat liver fibrosis?. Eur J Gastyoenterol Hepato1,2004,16( 1 ) :123-126.
7Galabrese F, Valente M, Giacometti C, et al. Parenchymal trans- forming growth beta-l: itstype II receptor and smad signaling pathway correlate with inflammation and fibrosis in chronic liver diseasw of valetiology. J Gastroenterol Hepatol, 2003,18 ( 12 ) : 1302-1308.